Ocular myasthenia: diagnostic and treatment recommendations and the evidence base.
about
Repetitive nerve stimulation of facial and hypothenar muscles: relative sensitivity in different myasthenia gravis subgroups.Juvenile myasthenia gravis: a paediatric perspectiveCurrent and emerging therapies for the treatment of myasthenia gravis.Neurological manifestations of Graves' disease: A case report and review of the literature.Clinical significance of detection of antibodies to fetal and adult acetylcholine receptors in myasthenia gravisAutoimmune myasthenia gravis: emerging clinical and biological heterogeneityAutoimmune myasthenia gravis.Treatment strategies for myasthenia gravis.Heat-shock proteins in clinical neurology.Treatment of myasthenia gravis: focus on pyridostigmine.Serum levels of matrix metalloproteinases: implications in clinical neurology.Treatment strategies for myasthenia gravis: an update.Patients with ocular symptoms referred for electrodiagnosis: how many of them suffer from myasthenia gravis?Treatment of ocular myasthenia gravis.Characterization of patients with ocular myasthenia gravis - A case series.Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus.Efficacy of Gaze Photographs in Diagnosing Ocular Myasthenia Gravis.Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis
P2860
Q34026134-07AD0099-080D-4973-B9AA-EA24BE0C28BDQ34029492-DBBBA3B9-F702-4D8A-A31E-66156878647EQ34879129-BE326270-A335-4824-A19B-FC4A482E4628Q36570587-285FFF7B-9F59-49B9-94C6-EFFD7A7D8082Q36694363-64DB6E17-D6D2-4271-A9ED-7CE4CFE69361Q37315963-1298ACD1-957B-42FE-9F22-3FA30AF94D3EQ37409490-1BF8AFFB-98D5-4E02-A80C-08FADA68E0C5Q37483922-3EEC7D6E-35AE-4C1A-8B47-241ADFDF495CQ37901289-D065EC35-A4EE-4A7A-8F20-C710D5A1D29FQ37911501-8D505829-672D-4318-854D-578300DDEB2CQ37977361-FB8065DC-10B9-4F3A-B848-3E4D5CACCA91Q38024858-6B56A01E-EA41-47F7-8CAC-AAD0D9090C88Q41141662-9001F068-421B-4081-BE64-3168088E12A0Q44970301-D473E674-BA9F-448C-B511-CD436A54E238Q49803402-203F7C97-5801-4D61-930C-7BD7E529071FQ54394750-9DA6DC50-6BAE-4445-9821-8A22F5BCDAA8Q55519294-EE9851B8-A1F2-4484-B210-2EDB4D7EFE49Q58047456-0F0600A2-B638-49D6-A476-C86954A682C5
P2860
Ocular myasthenia: diagnostic and treatment recommendations and the evidence base.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ocular myasthenia: diagnostic and treatment recommendations and the evidence base.
@en
Ocular myasthenia: diagnostic and treatment recommendations and the evidence base.
@nl
type
label
Ocular myasthenia: diagnostic and treatment recommendations and the evidence base.
@en
Ocular myasthenia: diagnostic and treatment recommendations and the evidence base.
@nl
prefLabel
Ocular myasthenia: diagnostic and treatment recommendations and the evidence base.
@en
Ocular myasthenia: diagnostic and treatment recommendations and the evidence base.
@nl
P1476
Ocular myasthenia: diagnostic and treatment recommendations and the evidence base.
@en
P2093
Henry J Kaminski
Uladzimir Luchanok
P356
10.1097/WCO.0B013E3282F4098E
P577
2008-02-01T00:00:00Z